Pallas Capital Advisors »

Aldeyra Therapeutics shares owned by Pallas Capital Advisors

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Pallas Capital Advisors from 13F filings

Historical chart of Pallas Capital Advisors investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Pallas Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Pallas Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $91k 17k 5.22
2025-06-30 $68k 18k 3.83

More positions owned by Pallas Capital Advisors

Bruker Corporation (BRKR)
Microsoft Corporation (MSFT)
Global Partners Com Units (GLP)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Intl (FNDF)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Dimensional Etf Trust Internatnal Val (DFIV)
Fidelity Covington Trust Enhanced Intl (FENI)
JPMorgan Chase & Co. (JPM)

View all positions for Pallas Capital Advisors

Top funds holding Aldeyra Therapeutics

Knoll Capital Management
Perceptive Advisors
BlackRock
Vanguard Group
Ardsley Advisory Partners
AQR Capital Management
D. E. Shaw & Co
Kingdon Capital Management
Geode Capital Management
Kennedy Capital Management
State Street Corporation
Jacobs Levy Equity Management
Acadian Asset Management
683 Capital Management
Morgan Stanley

View all funds holding Aldeyra Therapeutics